Income Statement Celemics, Inc.

Stocks

A331920

KR7331920009

Biotechnology & Medical Research

End-of-day quote Korea S.E. Other stock markets 05/08/2026			5-day change	1st Jan Change
9,950.00 ^KRW	+5.29%		-7.01%	+266.48%

06-24	Celemics, Inc. announced that it expects to receive KRW 9.999995577 billion in funding from Cnp Co., Ltd.	CI
05-29	Celemics, Inc. announced that it has received KRW 11.5999945 billion in funding	CI

4cdc.Axz8IHuSBa3w1fXD3jFPNgaBMSe1M8OX63rUJkq-j1o.W1fISUv6XMGzgaqThHN8B1TMZW-ER4b8qgLtUCXX9QhuaJdWKsNLyoOjpA

Published financial data: CELEMICS, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2016	2022	2023	2024	2025
Revenues	1.55B	8.73B	6.58B	6.72B	5.77B
Other Revenues, Total	-	-	-	-	-
Total Revenues	1.55B	8.73B	6.58B	6.72B	5.77B
Cost of Goods Sold, Total	1.3B	6.31B	5.06B	3.04B	2.9B
Gross Profit	252M	2.42B	1.52B	3.68B	2.87B
Selling General & Admin Expenses, Total	2.19B	5.4B	5.5B	4.69B	4.79B
Provision for Bad Debts	300M	152M	133M	-394M	67.26M
R&D Expenses	1.93B	2.21B	1.31B	966M	1.04B
Depreciation & Amortization - (IS)	118M	325M	280M	244M	217M
Amortization of Goodwill and Intangible Assets - (IS)	26.82M	50.63M	46.35M	39.13M	30.68M
Other Operating Expenses	33.38M	22.27M	29.51M	34.51M	43.02M
Other Operating Expenses, Total	4.6B	8.16B	7.29B	5.58B	6.19B
Operating Income	-4.35B	-5.73B	-5.77B	-1.9B	-3.32B
Interest Expense, Total	-372M	-53.86M	-39.83M	-26.64M	-15.21M
Interest And Investment Income	8.89M	718M	605M	438M	307M
Net Interest Expenses	-363M	664M	565M	412M	291M
Currency Exchange Gains (Loss)	-7.39M	86.99M	9.35M	128M	-27.21M
Other Non Operating Income (Expenses)	-1.16B	186M	14.1M	-93.98K	17.45M
EBT, Excl. Unusual Items	-5.87B	-4.8B	-5.18B	-1.36B	-3.04B
Gain (Loss) On Sale Of Investments	-	-	1.32B	13.63B	-1B
Gain (Loss) On Sale Of Assets	-	-	-9.96M	3.63M	7.06M
EBT, Incl. Unusual Items	-5.87B	-4.8B	-3.88B	12.27B	-4.04B
Earnings From Continuing Operations	-5.87B	-4.8B	-3.88B	12.27B	-4.04B
Net Income to Company	-5.87B	-4.8B	-3.88B	12.27B	-4.04B
Minority Interest	-	-	1.11K	8.07K	-1.35K
Net Income - (IS)	-5.87B	-4.8B	-3.88B	12.27B	-4.04B
Net Income to Common Incl Extra Items	-5.87B	-4.8B	-3.88B	12.27B	-4.04B
Net Income to Common Excl. Extra Items	-5.87B	-4.8B	-3.88B	12.27B	-4.04B
Per Share Items
Net EPS - Basic	-5.72K	-587.56	-474.72	1.5K	-494.41
Basic EPS - Continuing Operations	-5.72K	-587.56	-474.72	1.5K	-494.41
Basic Weighted Average Shares Outstanding	1.03M	8.16M	8.16M	8.16M	8.16M
Net EPS - Diluted	-5.72K	-588	-475	1.49K	-494.41
Diluted EPS - Continuing Operations	-5.72K	-588	-475	1.49K	-494.41
Diluted Weighted Average Shares Outstanding	1.03M	8.16M	8.16M	8.21M	8.16M
Normalized Basic EPS	-3.58K	-367.23	-396.68	-104.42	-232.92
Normalized Diluted EPS	-3.58K	-367.23	-396.68	-103.78	-232.92
Supplemental Items
EBITDA	-4.06B	-4.84B	-4.91B	-1.11B	-2.6B
EBITA	-4.32B	-5.68B	-5.72B	-1.86B	-3.29B
EBIT	-4.35B	-5.73B	-5.77B	-1.9B	-3.32B
EBITDAR	-3.97B	-4.82B	-4.82B	-918M	-2.39B
Normalized Net Income	-3.67B	-3B	-3.24B	-852M	-1.9B
Supplemental Operating Expense Items
Advertising Expense	75.21M	249M	127M	132M	-
Marketing Expenses	-	73.96M	155M	162M	122M
Selling and Marketing Expenses	500M	1.61B	1.05B	1.52B	1.35B
General and Administrative Expenses	71.85M	92.59M	101M	101M	102M
Research And Development Expense From Footnotes	1.93B	2.21B	1.31B	966M	1.04B
Net Rental Expense, Total	90.15M	21.29M	89.12M	193M	217M
Imputed Operating Lease Interest Expense	64.64M	-	27.01M	59.42M	59.14M
Imputed Operating Lease Depreciation	25.51M	-	62.11M	134M	158M
Maintenance & Repair Expenses, Total	10.76M	-	-	-	-

Fiscal Period: December	2016	2022	2023	2024	2025
Assets
Cash And Equivalents	1.26B	2.25B	2.58B	3.96B	3.21B
Short Term Investments	-	10.6B	8.11B	6.11B	2.7B
Total Cash And Short Term Investments	1.26B	12.85B	10.69B	10.07B	5.92B
Accounts Receivable, Total	397M	906M	649M	316M	750M
Other Receivables	32.9M	45.8M	2.87M	4.16M	2.59M
Total Receivables	430M	952M	651M	320M	753M
Inventory	289M	1.39B	943M	1.1B	1.47B
Prepaid Expenses	1.12M	155M	194M	109M	67.67M
Other Current Assets, Total	66.68M	270M	225M	459M	233M
Total Current Assets	2.05B	15.61B	12.71B	12.05B	8.44B
Gross Property Plant And Equipment	2.24B	3.06B	2.44B	1.8B	1.43B
Accumulated Depreciation	-571M	-	-	-	-
Net Property Plant And Equipment	1.67B	3.06B	2.44B	1.8B	1.43B
Long-term Investments	-	3.04B	2.51B	15.14B	14.03B
Other Intangibles, Total	224M	134M	88.11M	48.98M	18.3M
Other Long-Term Assets, Total	232M	369M	372M	368M	498M
Total Assets	4.17B	22.21B	18.12B	29.41B	24.41B
Liabilities
Accounts Payable, Total	346M	533M	113M	142M	91.9M
Accrued Expenses, Total	143M	142M	78.03M	72.67M	128M
Current Portion of Leases	-	368M	353M	335M	343M
Other Current Liabilities	533M	1.6B	1.11B	1.42B	719M
Total Current Liabilities	1.02B	2.64B	1.65B	1.97B	1.28B
Long-Term Debt	5.34B	-	-	-	-
Long-Term Leases	-	868M	514M	183M	33.81M
Other Non Current Liabilities	7.09B	109M	73.27M	75.46M	76.63M
Total Liabilities	13.45B	3.62B	2.24B	2.23B	1.39B
Common Stock, Total	516M	4.08B	4.08B	4.08B	4.08B
Additional Paid In Capital	897M	64.22B	64.22B	64.22B	64.22B
Retained Earnings	-10.71B	-48.65B	-52.52B	-40.26B	-44.29B
Comprehensive Income and Other	18.45M	-1.07B	104M	-861M	-990M
Total Common Equity	-9.28B	18.59B	15.88B	27.18B	23.02B
Minority Interest	-	-	22.29K	17.18K	17.3K
Total Equity	-9.28B	18.59B	15.88B	27.18B	23.02B
Total Liabilities And Equity	4.17B	22.21B	18.12B	29.41B	24.41B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	1.03M	8.16M	8.16M	8.16M	8.16M
ECS Total Common Shares Outstanding	1.03M	8.16M	8.16M	8.16M	8.16M
Book Value / Share	-9.04K	2.28K	1.95K	3.33K	2.82K
Tangible Book Value	-9.5B	18.45B	15.79B	27.14B	23B
Tangible Book Value Per Share	-9.26K	2.26K	1.93K	3.32K	2.82K
Total Debt	5.34B	1.24B	866M	518M	377M
Net Debt	4.08B	-11.61B	-9.83B	-9.55B	-5.54B
Debt Equivalent Oper. Leases	721M	170M	713M	1.54B	1.74B
Minority Interest, Total (Incl. Fin. Div)	-	-	22.29K	17.18K	17.3K
Inventories - Raw Materials, Total	284M	1.3B	971M	1B	1.26B
Inventories - Finished Goods, Total	15.8M	121M	9.04M	127M	256M
Inventories - Others	-500	-440	-200	200	-390
Machinery, Total	1.87B	1.63B	1.42B	1.2B	1.02B
Accumulated Allowance for Doubtful Accounts (Supple)	271M	964M	1.08B	648M	195M

Fiscal Period: December	2016	2022	2023	2024	2025
Net Income	-5.87B	-4.8B	-3.88B	12.27B	-4.04B
Depreciation & Amortization - CF	257M	844M	811M	753M	689M
Amortization of Goodwill and Intangible Assets - (CF)	26.82M	50.63M	46.35M	39.13M	30.68M
Depreciation & Amortization, Total	284M	894M	857M	792M	720M
(Gain) Loss From Sale Of Asset	-	-	4.35M	-3.63M	-7.06M
(Gain) Loss on Sale of Investments - (CF)	-	-	-1.32B	-13.63B	1B
Stock-Based Compensation (CF)	5.76M	53.86M	39.83M	514K	486K
Provision and Write-off of Bad Debts	264M	152M	105M	-394M	67.26M
Other Operating Activities, Total	1.72B	-253M	-180M	-219M	30.7M
Change In Accounts Receivable	4.08M	-7.38M	140M	372M	-560M
Change In Inventories	40.94M	-706M	439M	-151M	-385M
Change In Accounts Payable	-73.41M	171M	-420M	28.58M	90.09M
Change in Unearned Revenues	-	7.79M	151M	-	-
Change In Income Taxes	-451K	-37.7M	12.91M	33.49M	-5.47M
Change in Other Net Operating Assets	-153M	373M	-489M	522M	-513M
Cash from Operations	-3.78B	-4.15B	-4.53B	-380M	-3.6B
Capital Expenditure	-370M	-545M	-219M	-117M	-166M
Sale of Property, Plant, and Equipment	-	-	10M	-	50.79M
Sale (Purchase) of Intangible assets	-57.67M	-6M	-	-	-
Investment in Marketable and Equity Securities, Total	-	1.47B	5.5B	2.14B	3.41B
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	-	-21.27M	-2.76M	-128M
Other Investing Activities, Total	-81.2M	-22.96M	5.58M	14.83M	48.85M
Cash from Investing	-509M	894M	5.28B	2.04B	3.21B
Long-Term Debt Repaid, Total	-	-476M	-407M	-368M	-349M
Total Debt Repaid	-	-476M	-407M	-368M	-349M
Issuance of Common Stock	283M	-	-	-	-
Issuance of Preferred Stock	5B	-	-	-	-
Other Financing Activities, Total	-	-	23.55K	-	-
Cash from Financing	5.28B	-476M	-407M	-368M	-349M
Foreign Exchange Rate Adjustments	-34.26K	5.43M	-1.94M	82.84M	-13.25M
Miscellaneous Cash Flow Adjustments	-	-	-	-	-10
Net Change in Cash	993M	-3.73B	333M	1.38B	-748M
Supplemental Items
Cash Interest Paid	13.88M	-	-	-	419K
Levered Free Cash Flow	-2.81B	-	-3.22B	-163M	-2.76B
Unlevered Free Cash Flow	-2.58B	-	-3.2B	-146M	-2.75B
Change In Net Working Capital	-285M	-	231M	-368M	1.23B
Net Debt Issued / Repaid	-	-476M	-407M	-368M	-349M

Fiscal Period: December	2016	2022	2023	2024	2025
Profitability
Return on Assets	-73.33	-	-17.88	-5	-7.72
Return on Total Capital	116.06	-	-19.72	-5.35	-8.13
Return On Equity %	90.48	-	-22.49	56.97	-16.08
Return on Common Equity	90.48	-	-22.49	56.97	-16.08
Margin Analysis
Gross Profit Margin %	16.21	27.76	23.15	54.72	49.71
SG&A Margin	141.15	61.82	83.55	69.81	83.12
EBITDA Margin %	-261.47	-55.44	-74.7	-16.54	-45.15
EBITA Margin %	-278.02	-65.11	-87.02	-27.74	-57.1
EBIT Margin %	-279.75	-65.69	-87.73	-28.32	-57.63
Income From Continuing Operations Margin %	-377.95	-54.95	-58.92	182.56	-69.98
Net Income Margin %	-377.95	-54.95	-58.92	182.56	-69.98
Net Avail. For Common Margin %	-377.95	-54.95	-58.92	182.56	-69.98
Normalized Net Income Margin	-236.22	-34.35	-49.24	-12.69	-32.97
Levered Free Cash Flow Margin	-180.71	-	-49.02	-2.43	-47.93
Unlevered Free Cash Flow Margin	-165.75	-	-48.65	-2.18	-47.76
Asset Turnover
Asset Turnover	0.42	-	0.33	0.28	0.21
Fixed Assets Turnover	0.97	-	2.39	3.16	3.57
Receivables Turnover (Average Receivables)	2.93	-	8.46	15	10.82
Inventory Turnover (Average Inventory)	4.21	-	4.34	2.98	2.26
Short Term Liquidity
Current Ratio	2	5.9	7.71	6.11	6.58
Quick Ratio	1.66	5.22	6.88	5.27	5.2
Operating Cash Flow to Current Liabilities	-3.7	-1.57	-2.75	-0.19	-2.81
Days Sales Outstanding (Average Receivables)	124.85	-	43.13	24.4	33.74
Days Outstanding Inventory (Average Inventory)	86.99	-	84.06	122.69	161.27
Average Days Payable Outstanding	110.9	-	25.59	14.61	13.05
Cash Conversion Cycle (Average Days)	100.93	-	101.6	132.48	181.95
Long Term Solvency
Total Debt/Equity	-57.5	6.65	5.46	1.91	1.64
Total Debt / Total Capital	-135.29	6.24	5.17	1.87	1.61
LT Debt/Equity	-57.5	4.67	3.24	0.67	0.15
Long-Term Debt / Total Capital	-135.29	4.38	3.07	0.66	0.14
Total Liabilities / Total Assets	322.56	16.31	12.34	7.58	5.7
EBIT / Interest Expense	-11.69	-106.46	-144.87	-71.44	-218.5
EBITDA / Interest Expense	-10.92	-89.86	-123.36	-41.72	-171.17
(EBITDA - Capex) / Interest Expense	-11.92	-99.98	-128.86	-46.1	-182.07
Total Debt / EBITDA	-1.31	-0.26	-0.18	-0.47	-0.14
Net Debt / EBITDA	-1	2.4	2	8.59	2.13
Total Debt / (EBITDA - Capex)	-1.2	-0.23	-0.17	-0.42	-0.14
Net Debt / (EBITDA - Capex)	-0.92	2.16	1.91	7.77	2
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	109.6	-	-24.65	2.15	-14.16
Gross Profit, 1 Yr. Growth %	99.57	-	-37.18	141.48	-22.01
EBITDA, 1 Yr. Growth %	79.27	-	1.53	-77.38	134.31
EBITA, 1 Yr. Growth %	76.79	-	0.72	-67.44	76.68
EBIT, 1 Yr. Growth %	76.76	-	0.64	-67.02	74.66
Earnings From Cont. Operations, 1 Yr. Growth %	88.81	-	-19.21	-416.5	-132.91
Net Income, 1 Yr. Growth %	88.81	-	-19.21	-416.5	-132.91
Normalized Net Income, 1 Yr. Growth %	88.91	-	8.02	-73.68	123.07
Diluted EPS Before Extra, 1 Yr. Growth %	86.9	-	-19.22	-414.32	-133.12
Accounts Receivable, 1 Yr. Growth %	-40.19	-	-28.4	-45.52	137.41
Inventory, 1 Yr. Growth %	-12.37	-	-31.98	16.39	33.6
Net Property, Plant and Equip., 1 Yr. Growth %	7.72	-	-20.06	-26.19	-20.75
Total Assets, 1 Yr. Growth %	28.61	-	-18.43	62.34	-17.01
Tangible Book Value, 1 Yr. Growth %	143.76	-	-14.42	71.8	-15.24
Common Equity, 1 Yr. Growth %	150.43	-	-14.56	71.16	-15.32
Cash From Operations, 1 Yr. Growth %	52.69	-	9.25	-91.61	846.13
Capital Expenditures, 1 Yr. Growth %	-37.85	-	-59.76	-46.75	42.01
Levered Free Cash Flow, 1 Yr. Growth %	-	-	-	-94.94	1.6K
Unlevered Free Cash Flow, 1 Yr. Growth %	-	-	-	-95.42	1.78K
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	-	-	-12.27	-6.36
Gross Profit, 2 Yr. CAGR %	-	-	-	23.17	37.24
EBITDA, 2 Yr. CAGR %	-	-	-	-52.08	-27.2
EBITA, 2 Yr. CAGR %	-	-	-	-42.73	-24.15
EBIT, 2 Yr. CAGR %	-	-	-	-42.39	-24.1
Earnings From Cont. Operations, 2 Yr. CAGR %	-	-	-	59.91	2.05
Net Income, 2 Yr. CAGR %	-	-	-	59.91	2.05
Normalized Net Income, 2 Yr. CAGR %	-	-	-	-46.68	-23.37
Diluted EPS Before Extra, 2 Yr. CAGR %	-	-	-	59.35	2.02
Accounts Receivable, 2 Yr. CAGR %	-	-	-	-40.94	13.72
Inventory, 2 Yr. CAGR %	-	-	-	-11.02	24.7
Net Property, Plant and Equip., 2 Yr. CAGR %	-	-	-	-23.18	-23.52
Total Assets, 2 Yr. CAGR %	-	-	-	15.08	16.07
Tangible Book Value, 2 Yr. CAGR %	-	-	-	21.26	20.67
Common Equity, 2 Yr. CAGR %	-	-	-	20.93	20.39
Cash From Operations, 2 Yr. CAGR %	-	-	-	-69.73	-10.92
Capital Expenditures, 2 Yr. CAGR %	-	-	-	-53.71	-13.04
Levered Free Cash Flow, 2 Yr. CAGR %	-	-	-	-	-7.41
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-	-	-	-7.22
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	-	-	-	-12.9
Gross Profit, 3 Yr. CAGR %	-	-	-	-	5.77
EBITDA, 3 Yr. CAGR %	-	-	-	-	-18.67
EBITA, 3 Yr. CAGR %	-	-	-	-	-16.63
EBIT, 3 Yr. CAGR %	-	-	-	-	-16.62
Earnings From Cont. Operations, 3 Yr. CAGR %	-	-	-	-	-5.59
Net Income, 3 Yr. CAGR %	-	-	-	-	-5.59
Normalized Net Income, 3 Yr. CAGR %	-	-	-	-	-14.08
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	-	-	-5.61
Accounts Receivable, 3 Yr. CAGR %	-	-	-	-	-6.09
Inventory, 3 Yr. CAGR %	-	-	-	-	1.89
Net Property, Plant and Equip., 3 Yr. CAGR %	-	-	-	-	-22.38
Total Assets, 3 Yr. CAGR %	-	-	-	-	3.2
Tangible Book Value, 3 Yr. CAGR %	-	-	-	-	7.62
Common Equity, 3 Yr. CAGR %	-	-	-	-	7.38
Cash From Operations, 3 Yr. CAGR %	-	-	-	-	-4.65
Capital Expenditures, 3 Yr. CAGR %	-	-	-	-	-32.74